CompletedNot applicableNCT03068117
Malignant Mesothelioma - Can we Improve Quality of Life
Studying Pleural mesothelioma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Portsmouth Hospitals NHS Trust
- Principal Investigator
- Prof Anoop J Chauhan, PhD, FRCPPortsmouth Hospitals NHS Trust
- Intervention
- Regular Early Specialist Symptom Control Treatment (RESSCT)(other)
- Enrollment
- 319 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2017
Study locations (19)
- Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
- County Durham and Darlington NHS Foundation Trust, County Durham, Durham, United Kingdom
- Basildon and Thurrock University Hospitals NHS Foundation Trust - Basildon Hospital, Basildon, Essex, United Kingdom
- Mid Essex Hospital Services NHS Trust - Broomfield Hospital, Chelmsford, Essex, United Kingdom
- Hampshire Hospitals NHS Foundation Trust, Basingstoke, Hampshire, United Kingdom
- Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital, Portsmouth, Hampshire, United Kingdom
- University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom
- Norfolk & Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, United Kingdom
- Sherwood Forest Hospitals NHS Foundation Trust, Nottingham, Nottinghamshire, United Kingdom
- Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, Nottinghamshire, United Kingdom
- Taunton and Somerset NHS Foundation Trust - Musgrove Park Hospital, Taunton, Somerset, United Kingdom
- Ipswich Hospital NHS Trust, Ipswich, Suffolk, United Kingdom
- Northumbria Healthcare NHS Foundation Trust, North Shields, Tyne and Wear, United Kingdom
- Great Western Hospital NHS Foundation Trust, Swindon, Wiltshire, United Kingdom
- North Bristol NHS Trust - Southmead Hospital, Bristol, United Kingdom
- +4 more locations on ClinicalTrials.gov
Collaborators
British Lung Foundation · University of Oxford
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03068117 on ClinicalTrials.govOther trials for Pleural mesothelioma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07192900Fast TILs to Treat Metastatic Cancer Patients With Pleural DiseaseDavid Bartlett, MD
- RECRUITINGNANCT07126509Partial Pleurectomy (Surgery) for Unresectable Pleural MesotheliomaUniversity of Chicago
- RECRUITINGPHASE1, PHASE2NCT07121374NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility StudyUniversity Hospital, Antwerp
- RECRUITINGPHASE1NCT06885697Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including MesotheliomaNational Cancer Institute (NCI)
- RECRUITINGPHASE2NCT06840834Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and ChemotherapyIntergroupe Francophone de Cancerologie Thoracique
- RECRUITINGPHASE2NCT06875076Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural MesotheliomaThe First Hospital of Jilin University
- RECRUITINGPHASE2NCT06790082The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural MesotheliomaAalborg University Hospital
- RECRUITINGPHASE1NCT06566079Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid TumorsInSilico Medicine Hong Kong Limited